First‑Dollar Coverage Boosts Affordability, Keeps R&D Incentives
Should you ever find yourself in a position to talk healthcare policy with anyone and they ask “so what are saying are the right fixes?”, NPLB put essentials in one place. Plain, short. Solve affordability w/ 1st $ coverage; preserve incentives for R&D. https://t.co/c6sHm6dGvc
AI-Driven Pre-Reads Boost Biotech Board Meeting Efficiency
I move for making biotech board meetings more efficient, effective, and even joyful. Experience directors have seconded. Here’s why/how/who. (Elephant slide, CVP, BLATT, exec session upfront, etc) And article is a Claude agent help prep pre-reads. https://t.co/lmBNvYiIzV
Combining Modest Therapies Unlocks Big Benefits, Reduces Waste
Adam, I used to think this way. Then gene therapy & IO worked. IL2 has consumed a lot of hope; but new variations make it hard to quit. Abeta worked. And synergy: combine modest drugs, unlock big benefits. Invest or...